00:00
Growing Money
Growing Money
USD/RUB
EUR/RUB
Releases

Vanda Pharmaceuticals Sets August 5 Date for Q2 Earnings

Washington-based Vanda Pharmaceuticals will disclose its financial performance for the second quarter of 2026 on August 5, immediately following the closing of the market. The announcement precedes a scheduled conference call where executives plan to outline the company's fiscal standing and recent corporate developments to investors.

Vanda Pharmaceuticals Sets August 5 Date for Q2 Earnings

The conference call is set to begin at 4:30 PM ET. Participants can join the discussion by dialing 1-888-596-4144 domestically or 1-646-968-2525 for international callers, using the passcode 1843107. A live audio webcast will be available on the company website, where early registration is recommended to ensure proper software configuration.

For those unable to attend the live session, a replay will be accessible starting at 8:30 PM ET on August 5 through August 12. Domestic listeners can access the recording at 1-800-770-2030, while international callers should use 1-609-800-9909, referencing the same passcode. Vanda, currently focused on developing therapies for unmet medical needs, will provide further details on their portfolio during the presentation.

Share

Comments (0)

Leave a comment

No comments yet. Be the first!